7,184 Shares in Veeva Systems Inc. (NYSE:VEEV) Purchased by Goelzer Investment Management Inc.

Goelzer Investment Management Inc. bought a new position in shares of Veeva Systems Inc. (NYSE:VEEV) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 7,184 shares of the technology company’s stock, valued at approximately $1,508,000.

A number of other hedge funds also recently bought and sold shares of VEEV. Advisors Asset Management Inc. acquired a new stake in Veeva Systems in the 1st quarter valued at about $28,000. Vermillion & White Wealth Management Group LLC acquired a new stake in Veeva Systems in the 4th quarter valued at about $32,000. Blue Trust Inc. raised its position in Veeva Systems by 3,460.0% in the 2nd quarter. Blue Trust Inc. now owns 178 shares of the technology company’s stock valued at $33,000 after purchasing an additional 173 shares in the last quarter. First Financial Corp IN acquired a new stake in Veeva Systems in the 1st quarter valued at about $35,000. Finally, DT Investment Partners LLC acquired a new stake in shares of Veeva Systems during the 2nd quarter worth about $35,000. Institutional investors and hedge funds own 88.20% of the company’s stock.

Insider Activity

In other news, SVP Jonathan Faddis sold 2,353 shares of Veeva Systems stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $200.00, for a total value of $470,600.00. Following the completion of the sale, the senior vice president now owns 9,035 shares of the company’s stock, valued at $1,807,000. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 10.50% of the company’s stock.

Veeva Systems Stock Up 0.1 %

NYSE VEEV opened at $204.67 on Friday. Veeva Systems Inc. has a fifty-two week low of $162.72 and a fifty-two week high of $236.90. The stock has a market cap of $33.09 billion, a price-to-earnings ratio of 60.37, a price-to-earnings-growth ratio of 2.02 and a beta of 0.81. The business has a fifty day moving average of $203.71 and a 200-day moving average of $200.08.

Veeva Systems (NYSE:VEEV) last released its quarterly earnings results on Wednesday, August 28th. The technology company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.03. The company had revenue of $676.18 million during the quarter, compared to analysts’ expectations of $667.21 million. Veeva Systems had a return on equity of 13.30% and a net margin of 23.91%. As a group, analysts anticipate that Veeva Systems Inc. will post 4.21 EPS for the current year.

Wall Street Analysts Forecast Growth

VEEV has been the topic of several research analyst reports. Guggenheim raised their target price on Veeva Systems from $233.00 to $249.00 and gave the stock a “buy” rating in a research report on Tuesday, October 1st. Bank of America raised their target price on Veeva Systems from $204.00 to $240.00 and gave the stock a “neutral” rating in a research report on Thursday, August 29th. Citigroup raised their target price on Veeva Systems from $256.00 to $273.00 and gave the stock a “buy” rating in a research report on Tuesday, August 27th. JPMorgan Chase & Co. raised their target price on Veeva Systems from $203.00 to $208.00 and gave the stock a “neutral” rating in a research report on Monday, September 9th. Finally, UBS Group raised their target price on Veeva Systems from $185.00 to $215.00 and gave the stock a “neutral” rating in a research report on Monday, August 26th. One analyst has rated the stock with a sell rating, seven have given a hold rating and sixteen have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $230.65.

Veeva Systems Profile

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.